The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by ...

The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...

Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic are resolved. Consequently, compounding pharmacies must stop making their ...

There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and the resulting economic uncertainty. Hospitals are ...

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. The device is an atrio-ventricular interval modulation therapy, meaning it ...